Recruiting at 1 site No phase Esrd

Esrd study: Ergothioneine

Official title Repletion of Ergothioneine in Patients With Kidney Failure

ClinicalTrials.gov ID: NCT06487546

What this study is testing

What it's testing
The study wants to find out if taking a daily ergothioneine supplement can bring back the low blood levels seen in dialysis patients.
Who it's for
It is looking for adults who have end‑stage kidney disease and are receiving dialysis.
What's involved
Participants will take a daily ergothioneine supplement and have blood tests to measure its levels.
Time commitment
The study lasts for a few weeks, with regular blood draws and follow‑up visits as scheduled by the investigators.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • kidney failure receiving hemodialysis or peritoneal dialysis

You likely can't join if

  • blood transfusion within 90 days
  • taking supplements which contain ergothioneine

The study team makes the final eligibility decision.

Where it is enrolling

  • Palo Alto, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Palo Alto, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.